- Home
- MAN vs RLAY Comparison
MAN vs RLAY Comparison
Compare MAN & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MAN | RLAY |
|---|---|---|
| Founded | 1948 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 1988 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MAN | RLAY |
|---|---|---|
| Price | $29.15 | $8.42 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 7 |
| Target Price | ★ $40.67 | $16.00 |
| AVG Volume (30 Days) | 976.2K | ★ 2.1M |
| Earning Date | 01-29-2026 | 11-06-2025 |
| Dividend Yield | ★ 7.70% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $17,643,700,000.00 | $8,355,000.00 |
| Revenue This Year | $1.15 | $20.47 |
| Revenue Next Year | $3.60 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $26.14 | $1.78 |
| 52 Week High | $63.35 | $8.70 |
Technical Indicators
Market Signals| Indicator | MAN | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 50.28 | 67.67 |
| Support Level | $27.40 | $7.42 |
| Resistance Level | $29.26 | $8.70 |
| Average True Range (ATR) | 0.86 | 0.45 |
| MACD | 0.36 | 0.03 |
| Stochastic Oscillator | 69.84 | 81.63 |
Price Performance
Historical ComparisonAbout MAN ManpowerGroup
ManpowerGroup Inc. is engaged in providing workforce solutions and services. The company provides services that include Recruitment and Assessment, Upskilling, Reskilling, Training and Development, Career Management, Outsourcing, and Workforce Consulting. The reportable segments of the company are Staffing and Interim, Outcome-Based Solutions and Consulting, Permanent Recruitment, and Others. The Staffing and Interim segment derives the maximum of the company's revenue. The company derives maximum geographical revenue from the Southern European region.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).